Selinisol Tablets Price and Strength Overview

Selinexor (Selinexor), as a member of the selective inhibitor of nuclear export (SINE) family, has attracted widespread attention in the medical community through its unique anti-cancer mechanism. It has been shown to have significant efficacy in combination with dexamethasone in relapsed or refractory multiple myeloma (MM), while triple combination therapy with bortezomib and dexamethasone also provides new hope for previously treated multiple myeloma patients. In addition, selinesol has shown potential in the treatment of certain diffuse large B-cell lymphomas (DLBCL).

With the launch of the original drug selinesol in China and its successful inclusion in the national medical insurance directory, patients have received new treatment options. Currently, selinesol tablets on the domestic market mainly come in two specifications: 20 mg 12 tablets and 20 mg 16 tablets, with each box priced at more than 20,000 yuan. However, for patients who meet the medical insurance indications, the medical insurance reimbursement policy will greatly reduce their financial burden.

Turning to the international market, Seliniso’s price situation presents a different picture. Taking the US version as an example, the price of each box of 20mg*8 tablets is as high as more than 100,000 yuan, and the price may fluctuate due to exchange rate changes. This undoubtedly places a heavy burden on patients who require ongoing treatment.

A number of generic drugs of Seleniso have also emerged in overseas markets. These generic drugs are highly consistent in ingredients with the original drugs, but are much more affordable. For example, a pharmaceutical company in Laos has launched a 20mg*32-tablet generic version of selinexol. The price is only around RMB 2,000. Although it may change due to the exchange rate, it still provides a more affordable option for patients with limited financial conditions.